Two Israeli medical cannabis companies announced entering a strategic partnership to co-found development and clinical validation of a range of cannabis-based ADHD products.

The two companies, Yom Chai and Kaneh-B, will conduct joint scientific trials in Israel utilizing various cannabinoids to bridge the gap between patients and doctors to bring scientifically-validated products to market.

Scot Albert, CEO of Yom Chai said, “We are excited to be working with Ofer Segal CEO and Yahav Blaicher Co-Founder of Kaneh-B to formulate, manufacture, and distribute world class cannabis-based products to the international marketplace”.

Click here to read the complete article

Mordechai Sones ~ IsraelNationalNews.com

Recent News Articles

Tuesday May 21

Poll: Most of Illinois says marijuana should be legal - Cannabis News

in Politics

by Bruce Kennedy - Editor in Chief

A new poll by Global Strategy Group on behalf of Think Big Illinois, says a…

929 hits

Tuesday May 21

New Report Says US Cannabis Market Could Hit $22.7B By 2023 - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

A new report projects the cannabis market in the United States will reach $22.7 billion…

1099 hits

Tuesday May 21

We May Finally Know Where the Cannabis Plant Originated - Cannabis News

in Science

by Bruce Kennedy - Editor in Chief

Cannabis may have originated high on the Tibetan Plateau, according to an analysis of fossil…

1332 hits

Tuesday May 21

NFL, NFLPA will reportedly study marijuana as potential pain-management tool for players - Cannabis News

in Sports

by Bruce Kennedy - Editor in Chief

With talks of a new collective bargaining agreement underway, the NFL and NFL Players Association…

1385 hits

Wednesday May 22

Marijuana sales east of Mississippi poised to rival western markets - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

The cannabis industry in the United States has long been centered around such states as…

1063 hits